论文部分内容阅读
本文分析1964年3月～1970年12月收治123例卵巢恶性肿瘤(其中72.4%已有转移)的临床资料及疗效,各期总的五年生存率为34.7%。着重介绍了肿瘤切除术后腹腔内留置塑料管行抗癌药物灌注的体会,认为此法有提高疗效的作用:Ⅰ期死亡6例均未经此法治疗,五年健在15例中有9例经此法治疔;Ⅱ期五年健在7例中全部用过此法,其中一例治后至今8年仍健在,一例生存达6年始死亡,晚期病例用此法者其生存时间也较全身化疗者为长。对影响疗效的若干因素进行了讨论。
This article analyzes the clinical data and efficacy of 123 ovarian malignancies (72.4% of whom have metastases) from March 1964 to December 1970, with a total 5-year survival rate of 34.7%. Emphatically introduced the peritoneal indwelling plastic tube tumor anticancer drug perfusion experience, that this method has the effect of improving the efficacy: 6 cases of stage I were not treated by this method, five years in 15 cases, 9 cases After this rule of law 疔; Ⅱ five-year health in all of the seven cases were used in this method, one of eight cases after the treatment is still alive, one case of survival up to 6 years before the death of patients with advanced cases of this method, its survival time than systemic chemotherapy For long. Several factors affecting efficacy are discussed.